Stay updated on Cabozantinib for CNS Tumors in Children Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for CNS Tumors in Children Clinical Trial page.

Latest updates to the Cabozantinib for CNS Tumors in Children Clinical Trial page
- CheckyesterdayChange DetectedThe page shows a revision label updated from v3.5.3 to v3.5.4, indicating a small backend/software update rather than any change to the study details or visible content.SummaryDifference0.1%

- Check8 days agoChange DetectedIndiana University has been added to the collaborators/investigators section, replacing Indiana University School of Medicine. This reflects a shift in the listed institutional affiliation associated with the study team.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page’s footer revision/version number was updated from “v3.5.2” to “v3.5.3.” This reflects a site/package update rather than a change to the clinical trial’s content.SummaryDifference0.1%

- Check30 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib for CNS Tumors in Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for CNS Tumors in Children Clinical Trial page.